Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,714 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S, Nishida H, Komori T, Seki M, Komatsu T, Nakamagoe K, Ikeda T, Yoshida M, Takahashi T, Ono H, Nishiyama S, Kuroda H, Nakashima I, Suzuki H, Bradl M, Lassmann H, Fujihara K, Aoki M; Japan MOG-antibody Disease Consortium. Takai Y, et al. Among authors: ono h. Brain. 2020 May 1;143(5):1431-1446. doi: 10.1093/brain/awaa102. Brain. 2020. PMID: 32412053
Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD.
Kaneko K, Kuroda H, Matsumoto Y, Sakamoto N, Yamazaki N, Yamamoto N, Umezawa S, Namatame C, Ono H, Takai Y, Takahashi T, Fujimori J, Nakashima I, Harigaya Y, Lassmann H, Fujihara K, Misu T, Aoki M. Kaneko K, et al. Among authors: ono h. Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200293. doi: 10.1212/NXI.0000000000200293. Epub 2024 Aug 12. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39133885 Free PMC article.
The real-world impact of biologics for NMOSD: A retrospective single-center study compared with natural course and conventional treatments in Japanese.
Yamazaki N, Misu T, Matsumoto Y, Takai Y, Namatame C, Ono H, Kaneko K, Nishiyama S, Kuroda H, Takahashi T, Nakashima I, Fujihara K, Aoki M. Yamazaki N, et al. Among authors: ono h. Mult Scler Relat Disord. 2024 Dec;92:106176. doi: 10.1016/j.msard.2024.106176. Epub 2024 Nov 16. Mult Scler Relat Disord. 2024. PMID: 39579645
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.
Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ; PREVENT Study Group. Wingerchuk DM, et al. Ann Neurol. 2021 Jun;89(6):1088-1098. doi: 10.1002/ana.26049. Epub 2021 Feb 27. Ann Neurol. 2021. PMID: 33586143 Free PMC article. Clinical Trial.
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Normal brain imaging accompanies neuroimmunologically justified, autoimmune encephalomyelitis.
Takewaki D, Lin Y, Sato W, Ono H, Nakamura M, Araki M, Okamoto T, Takahashi Y, Kimura Y, Ota M, Sato N, Yamamura T. Takewaki D, et al. Among authors: ono h. Neurol Neuroimmunol Neuroinflamm. 2018 Apr 2;5(3):e456. doi: 10.1212/NXI.0000000000000456. eCollection 2018 May. Neurol Neuroimmunol Neuroinflamm. 2018. PMID: 29616233 Free PMC article.
2,714 results